Author Ohlenbusch, Andreas
-
2014 | Journal Article | Letter Note
An unusual mutation in the XPG gene leads to an internal in-frame deletion and a XP/CS complex phenotype
Lehmann, J.; Schubert, S.; Schaefer, A.; Apel, A.; Laspe, P.; Schiller, S. & Ohlenbusch, A. et al. (2014)
British Journal of Dermatology, 171(4) pp. 903-905. DOI: https://doi.org/10.1111/bjd.13035
Details DOI PMID PMC WoS
-
2015 | Conference Abstract
A NOVEL MUTATION IN THE XPA GENE RESULTS IN TWO TRUNCATED PROTEIN VARIANTS AND LEADS TO A SEVERE XP/NEUROLOGICAL SYMPTOMS PHENOTYPE
Lehmann, J.; Schubert, S.; Schaefer, A.; Laspe, P.; Ohlenbusch, A.; Gratchev, A. & Emmert, S. (2015)
Anticancer Research, 35(6)
Athens: Int Inst Anticancer Research.
Details WoS
-
2015 | Journal Article
A novel mutation in the XPA gene results in two truncated protein variants and leads to a severe XP/neurological symptoms phenotype
Lehmann, J.; Schubert, S.; Schaefer, A.; Laspe, P.; Haenssle, H. A.; Ohlenbusch, A. & Gratchev, A. et al. (2015)
Journal of the European Academy of Dermatology and Venereology, 29(12) pp. 2479-2482. DOI: https://doi.org/10.1111/jdv.12841
Details DOI PMID PMC WoS
-
2016 | Journal Article
A unique chromosomal in-frame deletion identified among seven XP-C patients
Schubert, S.; Rieper, P.; Ohlenbusch, A.; Seebode, C.; Lehmann, J.; Gratchev, A. & Emmert, S. (2016)
Photodermatology Photoimmunology & Photomedicine, 32(5-6) pp. 276-283. DOI: https://doi.org/10.1111/phpp.12251
Details DOI PMID PMC WoS
-
2017 | Journal Article
Expanding the genetic cause of multiple sulfatase deficiency: A novel SUMF1 variant in a patient displaying a severe late infantile form of the disease
Jaszczuk, I.; Schlotawa, L.; Dierks, T.; Ohlenbusch, A.; Koppenhöfer, D.; Babicz, M. & Lejman, M. et al. (2017)
Molecular Genetics and Metabolism, 121(3) pp. 252-258. DOI: https://doi.org/10.1016/j.ymgme.2017.05.013
Details DOI
-
2017 | Journal Article
Splice variants of the endonucleases XPF and XPG contain residual DNA repair capabilities and could be a valuable tool for personalized medicine
Lehmann, J.; Schubert, S.; Seebode, C.; Apel, A.; Ohlenbusch, A. & Emmert, S. (2017)
Oncotarget, 9(1) pp. 1012-1027. DOI: https://doi.org/10.18632/oncotarget.23105
Details DOI
-
2019 | Journal Article |
Severe neonatal multiple sulfatase deficiency presenting with hydrops fetalis in a preterm birth patient
Schlotawa, L.; Dierks, T.; Christoph, S.; Cloppenburg, E.; Ohlenbusch, A.; Korenke, G. C. & Gärtner, J. (2019)
JIMD Reports, 49(1) pp. 48-52. DOI: https://doi.org/10.1002/jmd2.12074
Details DOI
-
2021 | Journal Article | Research Paper |
A novel remitting leukodystrophy associated with a variant in FBP2
Gizak, A.; Diegmann, S.; Dreha-Kulaczewski, S.; Wiśniewski, J.; Duda, P.; Ohlenbusch, A. & Huppke, B. et al. (2021)
Brain Communications, 3(2) pp. fcab036. DOI: https://doi.org/10.1093/braincomms/fcab036
Details DOI PMID PMC
-
2021 | Journal Article | Research Paper |
Sulthiame impairs mitochondrial function in vitro and may trigger onset of visual loss in Leber hereditary optic neuropathy
Reinert, M.-C.; Pacheu-Grau, D.; Catarino, C. B.; Klopstock, T.; Ohlenbusch, A.; Schittkowski, M. & Wilichowski, E. et al. (2021)
Orphanet Journal of Rare Diseases, 16(1) art. 64. DOI: https://doi.org/10.1186/s13023-021-01690-y
Details DOI PMID PMC